Transplant Surgery »  Meet the Team »  Nephrology »  Sindhu Chandran, M.D.
Sindhu Chandran, M.D.

Sindhu Chandran, M.D.

Assistant Professor of Medicine
Division of Nephrology
Department of Medicine

Contact Information

Academic Office
Phone: (415) 353-8374
Fax: (415) 353-8974
sindhu.chandran@ucsf.edu
Open Popup
  • All India Institute of Medical Sciences, M.B., B.S., 2001
  • University of Arizona, Intern, Medicine, 2004-2005
  • University of Arizona, Resident, Medicine, 2005-2007
  • Stanford University, Fellow, Medicine, 2007-2010
  • University of California, San Francisco, Fellow, Medicine, 2010-2011
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology Subspecialty
  • Chronic Kidney Disease
  • Immunosuppression for Kidney Transplantation
  • Kidney Transplantation
  • Living Kidney Donor Transplantation
  • Transplant Nephrology
  • Kidney Allocation
  • New-onset Diabetes After Transplantation (NODAT)
  • Protocol Kidney Biopsies

Dr. Chandran is an Assistant Professor at UCSF in the Department of Medicine, Division of Nephrology. A kidney and pancreas transplant specialist, Dr. Chandran is board certified in internal medicine and nephrology. She earned her medical degree at All India Institute of Medical Sciences, and completed her residency at the University of Arizona, a nephrology fellowship at Stanford University, and a Transplant Nephrology Fellowship at UCSF.  

Most recent publications from a total of 25
  1. Lee BJ, McCulloch CE, Grimes BA, Chandran S, Allen IE, Delgado C, Hsu CY. Refining the Policy for Timing of Kidney Transplant Waitlist Qualification. Transplant Direct. 2017 Aug; 3(8):e195. View in PubMed
  2. Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. Polyclonal Regulatory T cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant. 2017 Jul 04. View in PubMed
  3. Wojciechowski D, Chandran S, Yang J, Sarwal M, Vincenti F. Retrospective Evaluation of the Efficacy and Safety of Belatacept with Thymoglobulin Induction and Maintenance Everolimus: A Single Center Clinical Experience. Clin Transplant. 2017 Jun 29. View in PubMed
  4. Wojciechowski D, Chandran S, Vincenti F. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant. 2017 May; 31(5). View in PubMed
  5. Chandran S, Stock PG. Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):385-387. View in PubMed
  6. Chandran S, Feng S. Current status of tolerance in kidney transplantation. Curr Opin Nephrol Hypertens. 2016 Nov; 25(6):591-601. View in PubMed
  7. Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients. Transplantation. 2016 Jun 1. View in PubMed
  8. Wojciechowski D, Chandran S. BK Virus Infection After Kidney Transplantation: The Data Are Mounting for a Personalized Approach. Transplantation. 2016 Apr; 100(4):703-4. View in PubMed
  9. Morgan TA, Chandran S, Burger IM, Zhang CA, Goldstein RB. Complications of Ultrasound-Guided Renal Transplant Biopsies. Am J Transplant. 2016 Apr; 16(4):1298-305. View in PubMed
  10. Safa K, Chandran S, Wojciechowski D. Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects. Drugs. 2015 Dec; 75(18):2171. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Sindhu Chandran, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X